SEZGİN BAYINDIR, Z. Et Al. 2021. Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy. ANTIOXIDANTS , vol.10, no.5 .

SEZGİN BAYINDIR, Z., Losada-Barreiro, S., Bravo-Diaz, C., Sova, M., Kristl, J., & Saso, L., (2021). Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy. ANTIOXIDANTS , vol.10, no.5.

SEZGİN BAYINDIR, ZERRİN Et Al. "Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy," ANTIOXIDANTS , vol.10, no.5, 2021

SEZGİN BAYINDIR, ZERRİN S. Et Al. "Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy." ANTIOXIDANTS , vol.10, no.5, 2021

SEZGİN BAYINDIR, Z. Et Al. (2021) . "Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy." ANTIOXIDANTS , vol.10, no.5.

@article{article, author={ZERRİN SEZGİN BAYINDIR Et Al. }, title={Nanotechnology-Based Drug Delivery to Improve the Therapeutic Benefits of NRF2 Modulators in Cancer Therapy}, journal={ANTIOXIDANTS}, year=2021}